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Abstract 
A novel 66 kDa GTP-binding protein, designated G,,, has been partially purified along with insulin receptor (IR) from human placenta. This protein 
binds I-azido-GTP, is ADP-ribosylated by pertussis toxin, phosphorylated by IR tyrosine kinase and cross-reacts with antibodies against synthetic 
peptides from the GTP-binding domain of G,, (P960). Phosphorylation of IR-p subunit and G,, by IR tyrosine kinase was almost completely inhibited 
by 100 FM GTPyS, >75% by 50 PM and 20-30% by 1 PM, while GDP at these concentrations had no significant effect on the phosphorylation. 
IR tyrosine kinase phosphorylated G,, at the tyrosine residues. These studies indicate regulation of IR tyrosine kinase activity by guanosine phosphates 
and involvement of G,, in insulin action. 
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1. Introduction 
Cellular events of insulin action begin with binding of 
insulin to the a-subunits of insulin receptor (IR). Such 
binding produces conformational changes in the trans- 
membranous IR-/3 subunits, activating their tyrosine ki- 
nase activity, which phosphorylates both IR-B subunits 
and other proteins as well [1,2]. This sequence of events 
is widely believed to represent one mechanism by which 
insulin’s signals are transduced. Furthermore, it has been 
proposed that insulin-induced aggregates of IR have sev- 
eralfold higher tyrosine kinase activity as compared to 
native (tetrameric) IR [3]. Although binding of insulin to 
IR and activation of its tyrosine kinase are well under- 
stood, subsequent steps in insulin signal transduction 
from IR to its effector are not known. However, there 
is indirect evidence to support the involvement of GTP- 
binding protein(s) which could mediate or relay insulin’s 
signal across the cell membrane. 
In recent years many approaches have been made to 
identify G-protein(s) involved in insulin’s action. A num- 
ber of investigators have used bacterial toxins (cholera 
and pertussis toxins) which are known to ADP-ribosyl- 
ate some of the G-proteins and alter their interactions 
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with the receptors. Cholera toxin, which ADP-ribosyl- 
ates primarily the stimulatory G-proteins (G,), has been 
shown to increase insulin-stimulated protein synthesis 
[4], and insulin inhibits stimulation of adenylate cyclase 
by this toxin [5]. Pertussis toxin, which ADP-ribosylates 
the inhibitory type of G-proteins (Gi) and G,, inhibits a 
number of insulin-stimulated cellular events such as glu- 
cose transport [6] and its metabolism [7], protein synthe- 
sis [4], and activation of cyclic AMP phosphodiesterase 
[8]. Interestingly, insulin inhibits pertussis toxin cata- 
lyzed ADP-ribosylation of Gi [9] and this toxin also at- 
tenuates insulin-induced inhibition of adenyl cyclase [8]. 
We have recently isolated a novel 66 kDa GTP-binding 
protein, Gi,, from human placenta and have shown that 
G, co-purifies with IR through DEAE-Sephacel and 
WGA-Agarose chromatography steps [ 1 l-131. The Gi, 
binds GTPyS and 8-azido-GTP in the presence of Mg2’, 
has GTPase activity, is ADP-ribosylated by pertussis 
toxin, co-purifies with IR, and is phosphorylated by the 
insulin-stimulated IR tyrosine kinase. Furthermore, we 
have demonstrated that addition of GTPyS to IR-G,,- 
fraction reduces insulin-binding to IR, and that addition 
of insulin increases the binding of GTPyS to Gi, by 3- to 
5-fold [12]. Other evidence implicating G-proteins in in- 
sulin’s action is the recent demonstration that a non- 
hydrolyzable GTP analog (GTPyS) slightly inhibits 
(22%) the insulin-induced phosphorylation of IR-p sub- 
unit and significantly (65%) the phosphorylation of other 
substrates using purified membranes [lo]. Decreased au- 
tophosphorylation of the IR-j? subunit has been attri- 
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buted to decreased insulin-binding to IR in the presence 
of GTP@. Jo et al. [14] have further demonstrated that 
an insulin receptor peptide stimulates GTPyS binding to 
a 67 kDa GTP-binding protein from human placenta. 
We now report almost complete inhibition of phospho- 
rylation of IR-#3 subunit and Gi, by GTPyS, and insulin- 
induced phosphorylation of G, at tyrosine residues(s) by 
IR. 
2. Materials and methods 
2.1. Chemicals 
Antibodies against a synthetic peptide from the GTP-binding region 
of G, (P960, sequence GTSNSGKSTIVQMK) which cross-react with 
a number of other G,-subunits, a, > a, > a, > a, > a, [15], were the kind 
gift from Dr. A.G. Gilman of The University of Texas Health Science 
Center at Dallas. Monoclonal antibodies against phosphotyrosine- 
linked to Agarose were purchased from- Sigma Chemical Co. 
lr-?iiGTPrS. lr-“PlATP and la-32PlNAD were mtrchased from New 
England Nuclear Division of DuPont. [y-‘*P]8-azido-GTP was pur- 
chased from ICN, Canada Ltd. Pertussis toxin was purchased from List 
Biochemicals, California. DEAE-Sepharose, Wheat Germ Agglutinin 
(WGA)-Sepharose, CHAPS, guanine nucleotides (GDP, GTP and 
GTPyS), trichloro acetic acid (TCA), trifluoro acetic acid (TFA), Pons- 
ceau8, TPCK-treated trypsin, polyvinyl pyrrolidone# (PVP-40), 
phosphoserine, phosphothreonine, and phosphotyrosine were obtained 
from Sigma Chemical Co., St. Louis, MO. Acetonitrile and isopropanol 
were purchased from Aldrich, Milwaukee, WI. Polyvinylidene di- 
fluoride (PVDF) membrane and Pre-coated thin layer chromatography 
(TLC) plates were obtained from Bio-Rad, Richmond, CA. and 
SybromBrinkman Instruments, New York, NY, respectively. [‘251]Insu- 
lin was a gift from Dr. Charles C. Stuart of The University of Texas 
Medical Branch, Galveston, Texas. 
2.2. Isolation of G, and IR 
Human placentae were obtained within 4 h of delivery and parenchy- 
ma1 tissue was dissected free of chorion, amnion, umbilical cord and 
large blood vessels. Unless otherwise specified, all the procedures were 
carried out at 4°C and all the solutions used in the purification con- 
tained 100 PM phenylmethyls~fonylfluoride (PMSF), 0.25 M sucrose 
and 0.15 M NaCl. The parenchvmal tissue was homozenized in 3 
volumes of 25 mM Tris-I-ICI, pH_7.4 containing 1 mM && using a 
Polytron (Kinamatica-GmbH, setting no. 4) for 2 min. The homogenate 
was centrifuged at 10,000 x g for 30 min using a Sorvall RCS-B high 
speed centrifuge. The supematant was fortified with MgSO, (0.2 mM) 
and centrifuged at 30,000 x g for 60 min. The membrane pellet was 
homogenized using a Potter-Elvehjem glass homogenizer in 25 mM 
Tris-HCl, pH 7.4 containing 1 mM CaCl, and centrifuged at 30,000 x g 
for 60 min. The pellet was washed once more and stored at -70°C. The 
membrane preparation was thawed and suspended in 10 volumes of 25 
mM Tris-HCl, pH 7.4 containing a final concentration of 5 mM EGTA, 
resuspended in a Polytron for 30 s and centrifuged at 30,OOOxg for 60 
min. 
For solubii~zation of membrane protein, the pellet was suspended in 
10 volumes of buffer A (SO mM HEPES-NaOH. DH 7.4. 0.25 M su- 
crose, 0.15 M NaCl, 100 &M PMSF) containing 1% CHAPS. After 45 
min of vigorous stirring at 4°C the sample was centrifuged at 
30,000 xg for 60 min and the supematant was diluted lo- 
fold with buffer A. The pellet was extracted once more following the 
same procedure. The extracts were pooled and immediately applied to 
a DEAE-Senhacel column (2.5 x 20 cm). eauilibrated with buffer A 
containing 0.1% CHAPS at a flow rate of 12 ml/h. The column was 
washed with 200 ml of equilibrating buffer containing 500 mM NaCl. 
This resulted in the elution of a significant amount of GTP-binding 
proteins. As observed by previous investigators 1161, this may represent 
several well characterized G-proteins (G,, G, and-G,). After washing 
the column thoroughly with 200 ml of buffer A containine 1 M NaCl. - _ 
elution of IR and Gi, was achieved by buffer A containing 0.1% Triton 
X-100 and 1 M NaCl. Fractions that contained both GTP~S-binding 
and insulin-binding activity were pooled, dialyzed against buffer A, and 
applied to a 10 ml WGA-Sepharose affinity column, equilibrated with 
buffer A containing 0.1% Triton X-100. Insulin receptor and Gi, co- 
eluted with the equilibrating buffer containing 0.3 M N-acetylglu- 
cosamine. Each fraction (5 ml) was analyzed for GTPyS-binding and 
insulin-binding activity. The fractions that had GTPyS-binding activity 
also had insulin-binding activity. These fractions were pooled and 
dialyzed extensively against equilibrating buffer. Unless otherwise spec- 
ified, this fraction (IR-G,,- fraction) was used for all the’studies de- 
scribed here. 
[3sS]G~~S-binding to G-Proteins was determined as described by 
Evans et al. 1161 and [‘*51]insulin-binding to IR was determined accord- 
ing to the method described by Fu~ta-Yama~chi et al. [17]. 
2.4. Phosphorylation of the IR-G,-fraction and immunoprecipitation 
Phosphorylation of the IR-G,,-fraction was performed in the absence 
and presence of insulin (100 nM) in a reaction mixture containing 5 mM 
MnCl,, 16 PM [r-‘*P]ATP, 60,000 cpm/pmol as described by Krupinski 
et al. [18]. The reaction was stopped by the addition of 5 x stop-buffer 
(50 mM HEPES-NaOH, pH 8.0,2 mM EDTA, 50 mM sodium pyro- 
phosphate, 10 mM sodium fluoride and 10 mM ATP). Subsequently, 
antiphosphotyrosine-Agarose was added (1:1) and incubated over- 
night. Unbound proteins were removed by washing with phosphate- 
buffered saline (20 mM ohosnhate. DH 7.4 and 0.15 M NaClf contain- . I . . 
ing 0.1% NP-40. Phospho~lated and Agarose-bound proteins were 
solubilized in 5 x Laemmli sample buffer [19] and separated by 7.5% 
SDS-PAGE under reducing conditions (5 mM ~-mer~ptoe~anol). 
8-Azido-GTP-binding [12], and ADP-ribosylation of G-proteins by 
Pertussis toxin [ZO], slab gel electrophoresis [ 191, and autoradiography 
were performed as described previously [12,16,18]. Western blot analy- 
sis using antibodies P960 was performed following the methods of 
Casey et al. [15]. 
2.5. Determination of phosphorylated amino acid residue(s) 
Placental membrane and detergent-solubilized membrane extract 
(1 ml) were activated by pre-incubation with 100 nM insulin [17]. Phos- 
phorylation was performed by incubating the insulin-activated sample 
with [32P]ATP for 30 min. at room temperature and precipitated with 
TCA (10% final, v/v) overnight at 4°C. The precipitate was centrifuged 
at 14,000xg for 15 min at 4°C washed twice with 2 volumes of ethyl 
ether. resuspended in Laemmli’s buffer. resolved on a 7.5% reducing 
SDS-PAGE, and el~troblotted onto a PVDF membrane. The mem- 
brane was stained for l-2 min with 0.1% Ponceau-S (in 1% acetic acid), 
washed quickly with water twice, neutralized immediately by washing 
with 200,uM NaOH for l-2 min, dried and wrapped in Saran wrap, and 
kept at -70°C for autoradiography. 
Five to six phosphorylated 66 kDa bands were carefully cut out, 
pooled in a microfuge tube, and blocked in 500 ~1 of 0.5% PVP-40 
dissolved in 100 mM acetic acid (to prevent adsorption of protease to 
the membrane during digestion) for 30 min at 37’C. Excess PVP-40 was 
removed by extensive washing with water (5-6 changes). The 66 kDa 
protein bands were cut into smaller pieces of approximately 1 mm x 1 
mm, put back into the same tube and were subjected to trypsin digestion 
(enzyme to substrate ratio, 1 : 20) in 200 ~1 of 100 mM NaHCO,, pH 
8.2lacetonitrile, 95:5 (v/v), at 37°C overnight. After the digestion the 
reaction mixture was lyophil~ed, responded in 500,ul of 6 N HCl and 
hydrolyzed under vacuum for 3 h at 110°C. The acid-hydrolyze digest 
was diluted 4-fold with distilled water, lyophilized, resuspended in 50 
~1 of trifluroacetic acid (TFA)/H,O [l&90 (v/v)], and immediately ap- 
plied to a narrow bore (2.1 mm id.) reverse-phase HPLC column 
(ODS/C,,). The phosphorylated amino acid residues were eluted with 
a o-60% linear gradient of acetonitrile containing 0.1% TFA. Elution 
profiles of 20 ,ug each of phosphoserine (p-ser), phosphothreonine 
(p-thr) and phosphotyrosine (p-tyr) were obtained under the similar 
elution conditions. 
The eluted fractions containing radioactivity and corresponding to 
phosphotyrosine (p-tyr) peak were collected, lyophilized, resuspended 
in 50 .ul of HPLC grade water, and applied to a pre-irrigated thin layer 
chromatography plate along with standards containing phosphoamino 
acids; p-se@), p-thr(T), and p-tyrCY). The phosphorylated amino acids 
were resolved by three irrigation cycles with resolving solvent (propi- 
onic aci~2-isopropano~water (20:7~10)) for 8 h each, followed by air 
drying. The TLC plates were developed by ninhydrin spray (0.33% 
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ninhydrin in ethanol), followed by heating at 60°C for 1 h. Finally, the 
plate was wrapped with Saran wrap and stored overnight at -70°C for 
autoradiography. 
2.6. Effect of GTPyS on the phosphorylation of IR;B subunit and G,, 
The IR-G+-fractions were first incubated with various concentrations 
of GDP andGTPyS in Tris buffer (50 mM Tris-HCl, pH 7.4 containing 
0.1% Triton X-100 and 100 uM PMSF). Subseauentlv. insulin (100 nM) 
II \ I 
was added to one set and to the other set eq;ivalent amount of Tris- 
buffer was added. The samples were further incubated for 1 h at 25”C, 
phosphorylated as described above, and subjected to 7.5% SDS-PAGE 
under reducing conditions. The gels were dried and subjected to autora- 
diography [I I]. 
3. Results 
Approximately 70% of total G-Proteins were eluted 
from the DEAE-Sephacel column with buffer A contain- 
ing 0.1% CHAPS and 0.5 M NaCl and the remaining 
30% eluted along with IR (as determined by [35S]GTPyS 
and [1251]insulin-binding) with 1 M NaCl in buffer A 
containing 0.1% Triton X-100. Almost all the IR and 
GTPyS-binding activity, eluted from DEAE-Sephacel 
column with 1 M NaCl, adsorbed on WGA-Agarose and 
co-eluted with 0.3 M ~-acetylglu~osa~ne [12]. This ob- 
servation indicated that either Gi, and some other GTP- 
binding proteins are complexed with receptors which are 
glycosylated, for example IR, or that some of the GTP- 
binding proteins may contain carbohydrate moieties. In 
the WGA-fraction, S-azido-GTP bound to 66 kDa, 45 
kDa, and 41 kDa proteins (Fig. 1, lanes 1,2). However, 
ADP-ribosylation in the presence of pertussis toxin indi- 
cated two major substrates (Fig. 1, lanes 3,4), one of 
4143 kDa and the other 66 kDa (GiJ. Similarly, anti- 
bodies against GTP-binding domain (P960) demon- 
strated two cross-reacting protein bands of 66 kDa and 
-4lK 
1 2 3 4 
Fig. 1. Characterization of placental Gi,. The WGA-Sepharose fraction 
containing IR-G,, was used for 8-azido-GTP-binding in the presence of 
200 PM ATP without (lane 1) and with (lane 2) exposure to UV light; 
for ADP-ribosylation in the absence (lane 3) and presence (lane 4) of 
pertussis toxin; and for Western blot analysis (lane 5) using antiserum 
p960. A 10% gel was used for SDS-PAGE. 
kDa - - IR-R 
kDa - 
1 kDa - 
31 kda - 
I 2 
Fig. 2. I~unopr~pi~tion of phospho~lat~ IR-/? and G,. Lane 1 
shows standard molecular weight markers. Lane 2 shows IR-fi and Gi, 
immunoprecipitated with monoclonal antiphosphotyrosine antibodies 
(autoradiograph). 
approximately 41 kDa (Fig. 1, lane 5). Antibodies P960 
absorbed by synthetic peptide P960 (corresponding to 
the GTP-binding domain of GA, did not cross-react 
with any protein on western blot (data not shown). 
Insulin-activated IR tyrosine kinase phospho~lated 
IR-p subunit as well as 66 kDa protein. The phosphoryl- 
ation of Gi, occurred at the tyrosine moiety as shown by 
the precipitation of the phosphorylated Gi, by monoclo- 
nal antibodies against phosphotyrosine (Fig. 2). Further- 
more, acid hydrolysis of 32P-phosphorylated Gi,, trans- 
ferred on PVDF after SDS-PAGE, followed by the sepa- 
ration of phosphorylated amino acids by reverse-phase 
high-performance liquid chromatography and analysis 
by TLC indicated that the phosphorylation occurred at 
the tyrosine moiety (Fig. 3). 
Phosphorylation of both IR-/3 subunit and G, was 
inhibited >75% by 50 PM and almost completely by 100 
PM GTPyS both in the absence or presence of 200 nM 
insulin (Fig. 4, top and bottom panels). Even 1 FM 
GTPyS inhibited insulin-induced phosphorylation by 
2%30%. On the other hand, 100 PM GDP had no signif- 
icant effect on the phosphorylation of IR and G, (data 
not shown). 
4. Discussion 
Thus far two distinct families of hormone signal 
transducing G-Proteins have been characterized, ‘low 
molecular weight G-proteins’ comprising only a single 
20-28 kDa polypeptide, and ‘classical heterotrimeric G- 
proteins’ consisting of CI, p, and y subunits 121-231. The 
G,-subunit binds guanine nucleotides (GTP and GDP), 
has GTPase activity, some types can be ADP-ribosylated 
by pertussis or cholera toxin, and can be phosphorylated 
by IR tyrosine kinase in the presence of biological mem- 
branes or liposomes [18]. There is a distinct diversity in 
the size of cr-subunits of the G-proteins, while /3- and 
y-subunits show a lesser degree of size variability [21]. 
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G,-subunits have a molecular weight of 39,000 to 54,000, 
however, a 74 kDa GTP-binding protein (GJ associated 
with a,-adrenergic receptors has also been isolated re- 
cently ]24]. Gur simultaneous demonstration of a 66 kDa 
protein (G,) in human placenta which exhibits all the 
properties of a G,-subunit, except size, further shows the 
presence of higher molecular weight GTP-birding pro- 
teins. 
Since Gi, has GTPase activity (1 l), it was not possible 
to study the effect of GTP on the phosphorylation of IR 
and Gti Instead, GTPyS which is not hydrolysed by 
GTPase was used. Differential inhibition of insulin re- 
ceptor phuspho~lation by GTPyS and GDP may indi- 
cate a regulatory role for guanine nucleotidets) assuming 
that the effect of GTP and GTPyS is similar. The GTPyS 
concentration that almost completely inhibits IR and Gi, 
phosphorylation in vitro is within the physiological 
range of GTP [25]. We have shown earlier that 100 ,uM 
GTPyS significantly inhibits insulin-binding to IR-G,- 
fraction [12], whereas Davis and McDonald [lo] have 
demonstrated that GDP increases insulin-binding to IR. 
Furthermore, prior binding of insulin to IR-Gi,-fraction 
increases high afIinity binding of GTPyS by J- to 5-fold 
[f2]. Therefore, it is reasonable to speculate that in viva, 
insulin binding to IR-a subunits would stimulate GTP- 
binding to G-proteins and activate IR-/I tyrosine kinase 
which in turn could phosphorylate Gi, and other G- 
proteins. GTP would decrease insulin binding to IR and 
could be hydrolysed to the GDP-bound form 
~~~~~,j which would increase insulin binding and would 
not affect phosphorylation of the IR tyrosine kinase. 
IO et al. [26] have also identified and partially purified 
two distinct GTP-binding proteins (67 and 41 kDa) that 
are associated with IR. The dissociation of these GTP- 
binding proteins from the IR results in loss of insulin- 
stimulated IR kinase activity which could be restored 
upon the addition of the former. The 67 kDa protein, 
which appears to be similar to our 66 kDa GTP-binding 
protein [ 1 l-l 33, could further be purified over the GDP- 
7111111 ,min , 
Fig. 3. Identification of phosphorylated tyrosine residues of Gi,. (A) 
~igh-pe~o~a~~~ liquid c~omato~aphy pro@e of p~os~hot~osine 
standard (20 ng), (R) thin layer ehromato~aphy profile of phsor- 
phorylated G,,. The left lane shows the separation of a mixture of 
standards [containing P-Ser(S), P-Thr(T) and P-Tyror)] stained with 
ninhydrin. The right lane shows the radiolabeled [3ZP]phosphotyrosine 
residues in acid-hydrolysed, HPLC-separated phosphorylated Gi,. 
Origin- 
95K- 
6 6E- 
Origin- 
95K- 
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Fig 4, Effect of GTPyS on the phosphorylation of insulin receptor 
/&subunit and Gk DEAF-Sephacel fraction containing IR-Gk was used 
for phospho~latio~ without (upper panel) and with (lower panel) 200 
nM insulin pre-incubation with at 25°C [16]. Samples after incubation 
with or without insulin were further incubated with GTPyS: none, (1); 
1 ,uM (2); 10 PM (3); 50 PM (4); 100 pM (5); and 500 PM (6). Subse- 
quently, phosphorylation mixture was added as described in the text. 
Afterwards proteins were separated on SDS-PAGE, stained with 
Coomassie blue and subjected to autora~o~aphy. 
agarose column, binds 8-azido-GTP and cross-reacts 
with antibodies [15] specific to G, subunit. The 41 kDa 
protein has characteristics of Gi-type protein and can be 
ADP-ribosylated in the presence of pertussis toxin. Re- 
cently, it has been shown that IR-j? subunit also pos- 
sesses two distinct binding/activating domains for GTP- 
binding proteins [14] similar to that of IGF-II/mannose 
G-phosphate receptor [27]. It has been reported that a 
synthetic peptide specific for one of these two domains, 
GPBP,, 1135-l 156 (G-proteins binding peptide, 1135 
I 156) increases GTPyS binding to the IR associated G- 
proteins by severalfold f14J. Cocozza et al, have sug- 
gested that a natural mutation of Arg + Gln at codon 
1152 (represented in GPBP,, 1135-l 156) in the exon 20 
of IR results into impaired IR kinase activity and could 
contribute to the insulin-resistant status in NIDDM pa- 
tients [ZS]. In purified IR preparations, ATP binds di- 
rectly to IR [29] and brings about conformational change 
in IR-j? [30] leading to its autophosphorylation. Guanine 
nucleotides (GTP/GMP-PEPS do not interfere in or 
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compete for ATP-binding to IR [29]. It is therefore likely 
that GTPyS binds to the G-proteins and not to IR. If IR 
and G-protein(s) are complexed, binding of GTPyS to 
Gi, would in turn affect properties of IR including insulin 
binding and IR tyrosine kinase activity. 
In conclusion, Gi, could play a role in at least some of 
insulin’s actions because: the 66 kDa GTP-binding pro- 
tein, Gi,, may be complexed with IR; insulin activates 
GTPyS-binding to Gi,; IR tyrosine kinase phospho- 
rylates Gi, and insulin stimulates it, GTPyS inhibits insu- 
lin-binding to IR while GDP stimulates it, and GTPyS 
(equivalent o physiological concentrations of GTP) al- 
most completely blocks phosphorylation of both IR-/I 
subunit and Gi,. Further studies are in progress to eluci- 
date the role of Gi, in insulin signal transduction. 
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